ISMP has a list of recommendations in the Targeted Medication Safety Best Practices for Hospitals including the removal of promethazine from hospitals
The ISMP Targeted Medication Safety Best Practices for Hospitals Serious tissue injuries and amputations from injectable promethazine use
by MR Cohen 2024 Cited by 32. Institute for Safe Medication Practices (ISMP): Action needed to prevent serious tissue injury with IV promethazine. ISMP Medication Safety Alert! Acute Care
by MR Cohen 2024 Cited by 32. Institute for Safe Medication Practices (ISMP): Action needed to prevent serious tissue injury with IV promethazine. ISMP Medication Safety Alert! Acute Care
by M Cohen 2024 Cited by 4Intravenous promethazine is one of the 12 medications on the list, and the only antiemetic. The ISMP, in its assessment of how hospitals in
2 According to the ISMP, diluting promethazine in an IV fluid, such as normal saline, reduces the vesicant effects and enables slow
by M Grissinger 2024 Cited by 22Preventing serious tissue injury with intravenous promethazine (phenergan). extravasation. Nonetheless, the ISMP believes that health care providers
and the. ISMP Medication Safety Alert! Community/Ambulatory Care Edition. Events involving these medications were reported to ISMP through either the ISMP
In 2024, IV promethazine was added to ISMP List of High Alert Medications in Acute Settings, and in ISMP Best practice recommends to remove all injectable promethazine from the hospital and to classify as non-formulary. ASHP issues policy position IV promethazine may used when clinically warranted, despite recognized risks.
Comments